Trials / Completed
CompletedNCT02180568
Lipiodol Localization for Ground-glass-opacity Minimal Surgery
Validation Study to Evaluate the Safety and Efficacy of Preoperative Computed Tomography-guided Localization Technique Using Lipiodol for Patients With Ground Glass Opacity Pulmonary Lesions: A Prospective Multicenter Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study object is to demonstrate the usefulness and safety of lipiodol localization technique for individuals undergoing ground-glass opacity (GGO) Video-assisted thoracic surgery (VATS) resection compared to hook wire localization technique. A total of 250 participants will be enrolled in a 1:1 fashion to Lipiodol or Hook-wire groups. If the aims of this study are achieved, the use of lipiodol localization technique will be widespread their application for localization of non-palpable pulmonary lesions that are indicated for VATS resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lipiodol | Lipiodol-guided lung localization technique |
| PROCEDURE | Hookwire | Hookwire-guided lung localization technique |
| DRUG | Lipiodol |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-12-01
- Completion
- 2017-12-01
- First posted
- 2014-07-02
- Last updated
- 2018-03-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02180568. Inclusion in this directory is not an endorsement.